![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Loba Biotech Gmbh Fischamend At, based in Austria, is a pharmaceutical company.
One of their significant offerings is Naphazoline Hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2021-445 - Rev 01
This Chemical Type CEP, issued on March 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 730 associated with this CEP further emphasizes